Clinical status and controversies

Intracoronary administration of cells derived from bone marrow in acute myocardial infarction. Ready for clinical use? Lessons from the ASTAMI trial

EuroIntervention Supplements (2007) 2 (Supplement B) B79-B83.

K Lunde
Ketil Lunde1*, MD; Svend Aakhus1, MD, PhD; Svein Solheim2, MD; Harald Arnesen2, MD, PhD; Torstein Egeland3, MD, PhD; Kolbjørn Forfang1, MD, PhD
1. Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway; 2. Department of Cardiology, Ullevål University Hospital, Oslo, Norway; 3. Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway

We designed the ASTAMI trial to investigate effects of intracoronary injection of autologous cells derived from bone marrow (BMC) in acute myocardial infarction (AMI) using robust and comprehensive methods. After

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

bone marrow cellsacute myocardial infarctionrandomised clinical trial
Read next article
Rationale and interim analysis data from the SEISMIC study

Latest news